On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...